Analysis of Proinflammatory Factors in the Synovial Fluid In Patients With Rotator Cuff Disease

February 16, 2010 updated by: Tel-Aviv Sourasky Medical Center

Role of proinflammatory factors in Patients with Rotator Cuff Disease

Objective:

To measure the levels of various cytokines and metalloproteases in patients with rotator cuff disease, and control group and to determine the correlations among them.

Study Overview

Status

Unknown

Detailed Description

We hypothesize that cytokines and MMP's level will be significantly higher in patients with RC pathology than in control group and will be related to the time frame since injury (i.e. - higher levels as close to the injury). In addition we will examine possible relation of those levels to the pain curve by using Visual Analogue Scale.

Study Type

Observational

Enrollment (Anticipated)

40

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

This study will include a consecutive series of patients who met the study inclusion criteria. Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment.

Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.

Description

Inclusion Criteria:

  1. Ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.
  2. Patients between age 18-65 scheduled for a surgery in a Shoulder unit
  3. Patients suffering from Rotator Cuff Disease
  4. Patients suffering from any noninflammatory shoulder condition which requires surgical intervention

Exclusion Criteria:

  1. Revision rotator cuff repair
  2. Recurrent shoulder surgery
  3. Psychiatric illness
  4. Inflammatory condition.
  5. Current use of anti-inflammatory drugs.
  6. Previous or current shoulder infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
RC tear
This study will include a consecutive series of patients who met the study inclusion criteria. Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment.
Control group
Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
cytokines and MMP's levels in patients with RC pathology and in control group
Time Frame: 12 month
12 month

Secondary Outcome Measures

Outcome Measure
Time Frame
Levels of pain curve by using Visual Analogue Scale
Time Frame: 12 month
12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (Anticipated)

March 1, 2011

Study Completion (Anticipated)

March 1, 2011

Study Registration Dates

First Submitted

February 9, 2010

First Submitted That Met QC Criteria

February 16, 2010

First Posted (Estimate)

February 17, 2010

Study Record Updates

Last Update Posted (Estimate)

February 17, 2010

Last Update Submitted That Met QC Criteria

February 16, 2010

Last Verified

February 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • MozesG

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Disease

Subscribe